|
|
Ngày nhập |
| 4784 |
In-use stability of ready-to- administer daratumumab subcutaneous injection solution in plastic syringes. EJHP |
04/11/2023 |
| 4785 |
Darzalex 1800 mg solution for injection - Summary of Product characteristics. Janssen-Cilag International NV |
04/11/2023 |
| 4770 |
Use of a liquid chromatography-tandem mass spectrometry method to assess the concentration of epinephrine, norepinephrine, and phenylephrine stored in plastic syringes. Pharmaceutical Technology in Hospital Pharmacy |
22/08/2023 |
| 4767 |
Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening. Pharmaceutical Technology in Hospital Pharmacy |
02/08/2023 |
| 4763 |
Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL) Pharmaceutical Technology in Hospital Pharmacy |
02/08/2023 |
| 4766 |
Stability of omeprazole extemporaneous oral solution in Chopin Base. Int J Pharm Compound |
02/08/2023 |
| 4768 |
Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019. Journal of Nippon Medical school |
02/08/2023 |
| 4769 |
Cisatracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages : A Stability Study Involving Four Degradation Products. Pharmaceutics |
02/08/2023 |
| 4762 |
Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature EJHP |
01/08/2023 |
| 4761 |
Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted- solutions in three infusion bags. Pharmaceutical Technology in Hospital Pharmacy |
28/07/2023 |
| 4759 |
Stability of 5-fluorouracil at 4°C, 25°C, and 33°C stored in NiproSureFuser+ Ambulatory Balloon Infusers. Sunnybrook Healt Science Centre |
10/07/2023 |
| 4757 |
In Vitro Assessment of Compounded Lurasidone Suspensions for Enteral Feeding Tubes. Hosp Pharm |
06/06/2023 |
| 4756 |
Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions. J Oncol Pharm Practice |
16/05/2023 |
| 4755 |
Extended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°C. J Oncol Pharm Practice |
03/05/2023 |
| 4754 |
Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions. J Oncol Pharm Practice |
26/04/2023 |
| 4747 |
Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease. Pharmaceutics |
24/04/2023 |
| 4748 |
Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment. Pharmaceutics |
24/04/2023 |
| 4750 |
Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation. Pharmaceutics |
24/04/2023 |
| 4751 |
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects. Pharmaceutics |
24/04/2023 |
| 4746 |
Stability and Compatibility of Bupivacaine and Hydromorphone in PVC and non-DEHP bags for 30 days at 4°C and 25°C. |
14/04/2023 |
| 4744 |
Stability Report of Extended SB8 Opened Vial (400 mg) Stability. |
07/04/2023 |
| 4745 |
Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags. Pharmaceutical Technology in Hospital Pharmacy |
07/04/2023 |
| 4742 |
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel |
02/04/2023 |
| 4741 |
Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base,
SuspendIt. Int J Pharm Compound |
29/03/2023 |
| 4740 |
MabThera 500 mg concentrate for solution for infusion. Summary of Product Characteristics Updated 07-Oct-2021 Roche Products Limited |
06/03/2023 |
| 4737 |
Extended Stability of Isoproterenol Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light Blocking Bags. Hosp Pharm |
04/03/2023 |
| 4739 |
Low-dose erythromycin in pediatrics: Formulation and stability of 20 mg hard gelatin capsules. PlosOne |
04/03/2023 |
| 4736 |
An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal |
20/02/2023 |
| 4735 |
Long-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bags. J Oncol Pharm Practice |
08/02/2023 |
| 4732 |
Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration. Am J Health-Syst Pharm |
02/02/2023 |
